Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Pfizer is close to selling its infant nutrition business to Nestlé for at least $9bn, people familiar with the matter told the Wall Street Journal....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...… Missed goal Has Seymour Pierce chairman Keith Harris lost his touch?...
...In the most recent series of developments, BarCap, Merrill, Morgan and Pierce, Fenner & Smith Inc filed suit against the site in March....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...But this was offset by disappointing earnings from drugmaker Pfizer....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...writes Craig Steven Jepson, a patent expert at Franklin Pierce Law Center, who filed a brief in the case....
...Reckitt Benckiser rose 0.8 per cent to £20.46 on reports that it was preparing a £6bn approach for the consumer medicines division of Pfizer of the US....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition